 |
市場調查報告書
商品編碼
1544612
口腔潰瘍治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032Mouth Ulcer Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
||||||
預計從 2024 年到 2032 年，口腔潰瘍治療市場規模將以 4% 的複合年成長率成長，這得益於口腔健康問題的患病率激增以及對可用治療方法的認知不斷增強。報告顯示，全球約有 35 億人面臨口腔健康問題。口腔潰瘍是一個普遍存在的問題，影響著相當一部分人群。人們對這些疾病的日益認知，再加上局部應用、口腔沖洗和全身藥物等有效治療方法，推動了市場的擴張。
口腔潰瘍治療的最新進展，包括增強的非處方藥解決方案、處方藥和替代療法，不僅提供了更有效的結果，而且滿足了更廣泛的患者需求。此外，對具有卓越功效、最小化副作用和提高患者依從性的產品的重視將進一步推動市場成長。
整個產業分為藥品類別、藥品劑型、適應症、配銷通路和地區。
根據藥物類別，抗組織胺領域的口腔潰瘍治療市場規模預計將在 2024 年至 2032 年間快速成長。透過抑制發炎反應，抗組織胺不僅可以緩解不適，還可以加速口腔潰瘍的癒合過程。
就藥物劑型而言，噴霧劑領域的口腔潰瘍治療市場預計將在 2024 年至 2032 年間出現強勁成長。口腔噴霧劑可以直接噴灑到受影響的區域，快速有效地將藥物輸送到最需要的地方。
亞太地區口腔潰瘍治療產業預計從2024 年到2032 年將出現顯著成長。是口腔潰瘍的已知先兆。此外，印度、中國和東南亞等國家正在見證醫療基礎設施的進步，並更加重視醫療保健的可近性，確保更好地提供專業治療和非處方解決方案。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 口腔潰瘍盛行率上升
- 提高認知和診斷
- 治療方案的進步
- 產業陷阱與挑戰
- 嚴格的監管要求
- 副作用和安全問題
- 成長動力
- 成長潛力分析
- 監管環境
- 技術景觀
- 核心技術
- 鄰近技術
- 未來市場趨勢
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 公司矩陣分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按藥物類別，2021 - 2032 年
- 主要趨勢
- 抗菌
- 抗組織胺藥
- 止痛藥和皮質類固醇
- 其他藥物類別
第 6 章：市場估計與預測：按藥物劑型，2021 - 2032 年
- 主要趨勢
- 噴霧劑
- 漱口水
- 凝膠
- 含片
第 7 章：市場估計與預測：按指標分類，2021 - 2032 年
- 主要趨勢
- 口瘡性口炎
- 口腔扁平苔癬
- 口腔念珠菌病
- 其他適應症
第 8 章：市場估計與預測：按配銷通路分類，2021 - 2032 年
- 主要趨勢
- 醫院藥房
- 零售藥局
- 網路藥局
第 9 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 10 章：公司簡介
- 3M Company
- Blistex Inc.
- Bristol Myers Squibb Company
- Church and Dwight Co., Inc.
- Colgate- Palmolive Company
- Dental Herb Company
- DR. Reddy's Laboratories Limited
- Forward Science
- GSK plc
- Johnson and Johnson
- Patterson Companies, Inc.
- Prestige Consumer Healthcare Inc.
- Pfizer, Inc.
- Prince Care Pharma Pvt Ltd
- Taro Pharmaceutical Industries Ltd.
Mouth ulcer treatment market size is predicted to grow at a 4% CAGR from 2024 to 2032 favored by the surging prevalence of oral health issues and a growing awareness of available treatments. Reports indicate that around 3.5 billion individuals globally grapple with oral health problems. Mouth ulcers, a prevalent concern, affect a notable segment of the population. The increasing acknowledgment of these ailments, combined with effective treatments like topical applications, oral rinses, and systemic medications, fuels the market expansion.
Recent advancements in mouth ulcer treatments, encompassing enhanced over-the-counter solutions, prescription drugs, and alternative therapies, not only provide more effective outcomes but also address a broader spectrum of patient needs. Moreover, the emphasis on products boasting superior efficacy, minimized side effects, and heightened patient adherence will further propel the market growth.
The overall industry is segmented into drug class, drug form, indication, distribution channel, and region.
Based on drug class, the mouth ulcer treatment market size from the antihistamine segment is poised to grow rapidly from 2024 to 2032. This surge is attributed to the proven efficacy of antihistamines in mitigating symptoms tied to allergic reactions and inflammation. By dampening the inflammatory response, antihistamines not only alleviate discomfort but also expedite the healing process of mouth ulcers.
In terms of drug form, the mouth ulcer treatment market from the sprays segment is expected to witness robust growth between 2024 and 2032. This owing to their convenience, ease of application, and targeted relief. Oral sprays provide direct application to the affected area, delivering medication quickly and effectively where it is needed most.
Asia Pacific mouth ulcer treatment industry is set to experience a notable growth rate from 2024 to 2032. Lifestyle shifts, notably a rise in processed food consumption and a dip in essential nutrient intake heighten the risk of nutritional deficiencies, a known precursor to mouth ulcers. Furthermore, nations like India, China, and in Southeast Asia are witnessing advancements in medical infrastructure and a heightened emphasis on healthcare access, ensuring better availability of specialized treatments and over-the-counter solutions.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of mouth ulcers
- 3.2.1.2 Increasing awareness and diagnosis
- 3.2.1.3 Advancements in treatment options
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Stringent regulatory requirements
- 3.2.2.2 Side effects and safety concerns
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Antimicrobial
- 5.3 Antihistamine
- 5.4 Analgesics and corticosteroids
- 5.5 Other drug classes
Chapter 6 Market Estimates and Forecast, By Drug Form, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Sprays
- 6.3 Mouthwash
- 6.4 Gels
- 6.5 Lozenges
Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Aphthous stomatitis
- 7.3 Oral lichen planus
- 7.4 Oral candidiasis
- 7.5 Other indications
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospital pharmacies
- 8.3 Retail pharmacies
- 8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 3M Company
- 10.2 Blistex Inc.
- 10.3 Bristol Myers Squibb Company
- 10.4 Church and Dwight Co., Inc.
- 10.5 Colgate- Palmolive Company
- 10.6 Dental Herb Company
- 10.7 DR. Reddy's Laboratories Limited
- 10.8 Forward Science
- 10.9 GSK plc
- 10.10 Johnson and Johnson
- 10.11 Patterson Companies, Inc.
- 10.12 Prestige Consumer Healthcare Inc.
- 10.13 Pfizer, Inc.
- 10.14 Prince Care Pharma Pvt Ltd
- 10.15 Taro Pharmaceutical Industries Ltd.
